Hoppenot Herve insider trades
Hoppenot Herve has filed 22 Form 4s with the SEC that we hold, for Incyte Corp (INCY) (Director), Bicycle Therapeutics PLC (BCYC) (Director) and Maze Therapeutics, Inc. (MAZE) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $19.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($19.8M). The largest single trade was a sale of 187,500 shares of Incyte Corp worth $19.8M, dated 2025-11-10. The first filing on our record is dated 2021-07-07 and the latest 2026-06-10.
Incyte Corp (INCY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-10 | S, sale reported on Form 4 | 187,500 | $19.8M | 2025-11-12 |
Bicycle Therapeutics PLC (BCYC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Maze Therapeutics, Inc. (MAZE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1596492) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms